Develops hormone replacement therapy products for menopause and andropause patients.
Jun 2026Revenue $184M/yrExpenses $169M/yr
No trend
Figures by year
Is biote profitable?
Yes. In the 12 months to Jun 2026, revenue was $184M and expenses $169M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $192M | $157M | $35.6M |
| Dec 2024 | $197M | $166M | $31.6M |
| Dec 2023 | $185M | $157M | $28.7M |
| Dec 2022 | $165M | $226M | −$60.7M |
| Dec 2021 | $139M | $105M | $34.6M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.